Weiss, L., Heinemann, V., Fischer, L. E., Gieseler, F., Hoehler, T., Mayerle, J., . . . Haas, M. (2024). Three-month life expectancy as inclusion criterion for clinical trials in advanced pancreatic cancer. Clinical and Translational Oncology, 26(5), 1268-1272. https://doi.org/10.1007/s12094-023-03323-1
Chicago-referens (17:e uppl.)Weiss, Lena, et al. "Three-month Life Expectancy as Inclusion Criterion for Clinical Trials in Advanced Pancreatic Cancer." Clinical and Translational Oncology 26, no. 5 (2024): 1268-1272. https://doi.org/10.1007/s12094-023-03323-1.
MLA-referens (9:e uppl.)Weiss, Lena, et al. "Three-month Life Expectancy as Inclusion Criterion for Clinical Trials in Advanced Pancreatic Cancer." Clinical and Translational Oncology, vol. 26, no. 5, 2024, pp. 1268-1272, https://doi.org/10.1007/s12094-023-03323-1.
